TL;DR
NICE published draft guidance in September 2026 recommending BDD screening before cosmetic procedures. It is not yet final.
Nearly 1 in 5 people attending aesthetic and reconstructive plastic surgery services show clinically significant BDD symptoms, compared with around 2% of adults overall.
Under the draft, practitioners would ask structured questions at consultation, record the results, and refer rather than treat when BDD is suspected.
Clinics can prepare now by reviewing consultation forms, setting up referral routes and training staff.
What has NICE proposed?
Now, you know we love to hear about improvements in patient safety in aesthetics. And, amazingly, it’s been a busy couple of updates.
Last week, we wrote about the government’s plans to restrict who can perform high-risk cosmetic procedures in England. And then, on 17 September 2026, NICE published draft guidance on identifying and treating obsessive-compulsive disorder (OCD) and body dysmorphic disorder (BDD). It includes new recommendations for anyone providing cosmetic treatments.
It’s important to note that the consultation closed on 21 October 2026, so the final guideline may still change. But in this article, we’ll give you a breakdown of what we know, so far.
NICE describes BDD as “a mental health condition in which a person becomes excessively preoccupied with perceived flaws in their appearance.”
They highlight that around 2% of adults in the UK show BDD symptoms. But when it comes to people seeking cosmetic treatment, this figure rises to 1 in 5 (18.6%) according to a 2024 meta-analysis. That is roughly nine times the rate in the wider population, and not a figure any clinic can ignore.
Why does the NICE draft guidance matter?
A patient with BDD might seek out a treatment they believe will make them feel better. But NICE’s guideline committee noted that cosmetic procedures rarely improve the underlying condition and can sometimes even exacerbate symptoms. Without the right support, a patient may keep returning for more treatments in pursuit of a result that never feels good enough.
Asking the right questions at consultation helps you spot patients who may be struggling with BDD. You can then refer them for specialist assessment, rather than risk making their condition worse.
Eric Power, interim director of the Centre for Guidelines at NICE, explains:
“Our draft recommendations aim to help healthcare professionals recognise symptoms earlier, ask the right questions and support people to access appropriate treatment sooner.
“Earlier identification can help ensure people receive care that reflects their needs, preferences and circumstances, rather than waiting until symptoms become more severe or reach crisis point.”
What does the draft mean for your clinic?
If the draft goes ahead as it’s currently written, clinics across England would need a routine BDD screening step, where you’ll be expected to ask 7 key questions:
Do you worry a lot about your appearance or find yourself preoccupied by it and wish you could think about it less?
What are your specific concerns?
On a typical day, how long do you think about your appearance, or how long is it on your mind for (e.g. more than an hour)?
How much time do you spend checking or comparing your appearance to others?
How much time do you spend trying to change, hide or conceal your appearance?
What effect do your thoughts about your appearance have on your life?
Do thoughts about your appearance get in the way of your day-to-day life, or cause distress?
If, after the recommended questions, there’s no indication of any signs of BDD, you’ll be able to go ahead as planned.
But if the patient shows signs they may be affected by BDD, don’t carry out the treatment or procedure. Instead:
Sensitively explain why
Refer the patient to a professional who specialises in BDD
Don’t make any comments about their appearance (not even positive ones)
While the NICE guidance isn’t law, it is widely accepted as the benchmark for good practice. So, training your staff in how to sensitively recognise BDD and handle conversations around it with care is a must.
What patients can expect
For the majority of patients, screening will just be a few extra questions during the consultation process - all of which should just feel like a normal step, not like a pass or fail test.
If a patient appears to be affected by BDD, explain the referral calmly and in private. It’s not about providing a diagnosis - it’s just about highlighting wellbeing and making sure they don’t feel shame or judgment.
Quick answers
Is the NICE guidance now in force?
No. It is draft guidance. The consultation closed on 21 October 2026, and NICE will publish a final version once it has considered the responses. The final wording may differ from the draft.
Does it apply to non-surgical aesthetic practitioners?
The draft names surgeons, dentists and dermatologists among those providing cosmetic treatments. Non-surgical practitioners such as aesthetic nurses and injectors aren’t named explicitly, but the guidance is likely to be seen as the expected standard across cosmetic practice.
Is NICE guidance legally binding?
No. But it is widely used as the benchmark for good practice, so it could be relevant if a complaint or claim is ever made about how a patient was assessed.
Does it apply outside England?
NICE guidance applies mainly to England. Scotland, Wales and Northern Ireland have their own arrangements, though NICE guidance is often influential there too.
Which screening questions should we use?
The draft recommends asking structured questions about appearance-related concerns, but doesn’t name a specific tool. Wait for the final guideline before settling on one, and take clinical advice when you choose.
Does a positive screen mean the patient has BDD?
No. Screening only suggests that BDD may be present. A diagnosis can only come from a specialist assessment, which is why the draft recommends referral.
Can we treat the patient after they’ve been referred?
The draft advises against proceeding with the procedure at that stage. Any decision to treat later should follow the outcome of the specialist assessment.
What if a patient refuses a referral?
The draft doesn’t cover this directly. Record the conversation and the patient’s decision, and take clinical and legal advice on your clinic’s policy.
What to do now
The final NICE guidance may still change, but there’s no harm in reviewing your processes now. What’s the saying? “Why wait for tomorrow what can be done today?”.
Start with your consultation forms, check that you have a clear referral route for patients who may be affected by BDD, and make sure your team knows how to handle these conversations sensitively.
The aim isn't to diagnose BDD in the treatment room. It's to recognise when a patient may need additional support and know what to do next.